park bldg

Since 1975, the University of Utah has been the primary contract site for the NINDS-­‐funded Anticonvulsant Screening Program (ASP; now ETSP), to perform preclinical studies to identify new treatments for epilepsy. Current efforts are focused on identifying treatments to address unmet needs in epilepsy, including pharmacoresistant epilepsy, comorbidities, and disease prevention/modification.

Share this article: